SearchPrescient Therapeutics
Article Timeline
BNiQ Network Graph
B
N
iQ
Displaying all people that are connected to 2 or more organisations. Hover over a node to display a link to the BNiQ page for that person or organisation.
Notable People
Showing 5 people. Position shown in italic is their previous role in the same organisation.
Most Senior WA Executive.
| Name | Position | Year Started |
|---|---|---|
| Non-Executive Director | 2014 |
| Non-Executive Chairman | 2014 |
| Non-Executive Director Executive Director (2014 to 2017) | 2017 |
| Vice President, Business Development | 2018 |
| Chief Executive Officer, Managing Director | 2014 |
Past People
| Name | Position | Year Started | Year Ended |
|---|---|---|---|
| Paul Hopper | Executive Director | 2014 | 2017 |
| Sean Henbury | Company Secretary | 2013 | 2015 |
| Rob Crombie | Managing Director | 2014 | 2015 |
| Wayne Millen | Non-Executive Chairman | 2013 | 2014 |
| Brendan de Kauwe | Non-Executive Director | 2013 | 2014 |
| Roland Toder | Non-Executive Director | 2013 | 2014 |
ECM Deals
| Date | Company | Transaction Type | Total Value | |
|---|---|---|---|---|
| 30/06/16 | Prescient Therapeutics | Entitlement offer | $3.4m | >> |
| 18/05/16 | Prescient Therapeutics | Placement | $7.0m | >> |
| 23/11/15 | Prescient Therapeutics | Entitlement offer | $1.0m | >> |
| 28/03/14 | Prescient Therapeutics | Placement | $3.0m | >> |
M&A Deals
| Announced | Bidder | Target | Transaction Type | Total Value | |
|---|---|---|---|---|---|
| 17/03/14 | Prescient Therapeutics | Pathway Oncology | Reverse takeover | $3.6m | >> |
Biography
Prescient Therapeutics, formerly known as Virax Holdings, is a clinical stage oncology company developing novel compounds that show great promise as potential new therapies to treat a range of cancers that have become resistant to front line chemotherapy.Biography last updated 06 Mar 2019
Share Transactions
Total value as at the date of the transaction
Source: Morningstar
BNiQ Disclaimer
Some of the information on ASX-listed public companies is sourced from Morningstar Australasia Pty Ltd (ABN: 95 090 665 544).
It is important to note that the Morningstar information displayed by Business News is not to be copied or distributed except as authorised; and that such information is not warranted to be accurate, complete or timely and that neither Morningstar nor Business News are responsible for any damages or losses arising from any use of this information.
The information is general information only and does not constitute financial advice It is not intended to be, and should not be construed in any way as, investment, legal or financial advice
Retail clients should be advised the Morningstar Financial Services Guide can be found at http://www.morningstar.com.au/fsg.asp
Show moreIt is important to note that the Morningstar information displayed by Business News is not to be copied or distributed except as authorised; and that such information is not warranted to be accurate, complete or timely and that neither Morningstar nor Business News are responsible for any damages or losses arising from any use of this information.
The information is general information only and does not constitute financial advice It is not intended to be, and should not be construed in any way as, investment, legal or financial advice
Retail clients should be advised the Morningstar Financial Services Guide can be found at http://www.morningstar.com.au/fsg.asp
